LRRK2 and Parkinson disease: Among the participants with light abnormal “eagle wing” DAT -SPECT scans, 72 percent (13/18) have preclinical LRRK2 PD, 22 percent (4/18) have prodromal LRRK2 PD and the one control patient accounted for 6%.